Welcome to our dedicated page for Thermo Fishr Sci news (Ticker: TMO), a resource for investors and traders seeking the latest updates and insights on Thermo Fishr Sci stock.
Thermo Fisher Scientific Inc. (TMO) is a global leader in life sciences, diagnostics, and laboratory innovation, providing essential tools for scientific research and healthcare advancements. This dedicated news hub offers investors and industry professionals timely updates on TMO's strategic initiatives, financial performance, and technological breakthroughs.
Access curated press releases and articles covering earnings reports, product launches, acquisitions, and partnerships. Our repository ensures you stay informed about developments in analytical technologies, diagnostic solutions, and biopharma services that shape the company's growth trajectory.
Discover updates across TMO's core operations: analytical instrumentation advancements, life science research tools, and specialty diagnostic innovations. Bookmark this page for streamlined access to verified information supporting informed analysis of Thermo Fisher's market position and industry impact.
Thermo Fisher Scientific released its 2023 Corporate Social Responsibility (CSR) report, detailing the company's commitments and progress in various areas. The report highlights the company's efforts in community support, environmental sustainability, and workforce development. Thermo Fisher employees volunteered over 100,000 hours globally and engaged more than 60,000 students in STEM competitions. The company is committed to achieving net-zero emissions by 2050, utilizing 41% renewable energy, and aims for 80% renewable electricity by 2030. Workforce initiatives include new training programs and enhanced wellness resources.
Thermo Fisher Scientific (NYSE: TMO), a leading entity in the science sector, has declared a quarterly cash dividend of $0.39 per common share.
This dividend is scheduled for payment on July 15, 2024, to shareholders recorded by June 14, 2024.
Thermo Fisher Scientific Inc. (NYSE: TMO) will have its chairman, president, and CEO present at the BofA Securities Health Care Conference on May 14, 2024. The live webcast will be available on the company's website.
Thermo Fisher Scientific, a global leader in scientific services, extends the expiration of the tender offer for all outstanding common shares and ADSs of Olink. The offer, scheduled to expire on June 18, 2024, aims to acquire Olink Holding AB for $26.00 per share in cash. As of April 30, 2024, approximately 94.3% of outstanding shares have been tendered. Completion of the offer is subject to regulatory approval.
FAQ
What is the current stock price of Thermo Fishr Sci (TMO)?
What is the market cap of Thermo Fishr Sci (TMO)?
